Connection

Isabella Eckerle to Rituximab

Back to Details
This is a "connection" page, showing publications Isabella Eckerle has written about Rituximab.
Isabella Eckerle
Connection Strength
0.031
Rituximab
  1. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery. Front Immunol. 2021; 12:613502.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.